Related content

Metformin administration modulates neurosteroids secretion in non-obese amenorrhoic patients with polycystic ovary syndrome

By Genazzani Alessandro   Strucchi Claudia   Luisi Michele   Casarosa Elena   Lanzoni Chiara   Baraldi Enrica   Ricchieri Federica   Mehmeti Hilda   Genazzani Andrea  

Gynecological Endocrinology, Vol. 22, Iss. 1, 2006-01 ,pp. : 36-43

Informa Healthcare

Access to resources Recommend Favorite

Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome

By Yilmaz Murat   Bi˙ri˙ Aydan   Bukan Neslihan   Karakoç Ayhan   Sancak Banu   Törüner Füsun   Paşaoğlu Hatice  

Gynecological Endocrinology, Vol. 20, Iss. 5, 2005-05 ,pp. : 258-263

Informa Healthcare

Access to resources Recommend Favorite

Metformin versus flutamide in the treatment of metabolic consequences of non-obese young women with polycystic ovary syndrome: a randomized prospective study

By Sahin I   Serter R   Karakurt F   Demirbas B   Culha C   Taskapan C   Kosar F   Aral Y  

Gynecological Endocrinology, Vol. 19, Iss. 3, 2004-09 ,pp. : 115-124

Informa Healthcare

Access to resources Recommend Favorite

Low‐dose combination of flutamide, metformin and an oral contraceptive for non‐obese, young women with polycystic ovary syndrome

By Ibáñez Lourdes  

Human Reproduction, Vol. 18, Iss. 1, 2003-01 ,pp. : 57-60

Oxford University Press

Access to resources Recommend Favorite

A randomized controlled trial evaluating metformin pre-treatment and co-administration in non-obese insulin-resistant women with polycystic ovary syndrome treated with controlled ovarian stimulation plus timed intercourse or intrauterine insemination

By Palomba Stefano  

Human Reproduction, Vol. 20, Iss. 10, 2005-10 ,pp. : 2879-2886

Oxford University Press

Access to resources Recommend Favorite